Your Eye Pressure Is High. Your Genes May Be Why.

CFH is your eye’s immune guard. It regulates the complement system in your retina, controlling inflammation that would otherwise damage your photoreceptors and retinal pigment epithelium. When complement is working normally, it clears dead cells and pathogens without harming healthy tissue. When it’s overactive or poorly regulated, it drives chronic inflammation in the back of the eye.

The CFH Y402H variant is the most common genetic risk factor for age-related macular degeneration and is strongly associated with elevated intraocular pressure and optic nerve vulnerability. Roughly 30-40% of people carry the H allele, which impairs complement regulation in the retina and increases your eye’s inflammatory burden. This is especially critical because the eye is an immune-privileged site; once inflammation starts, it’s harder to control.

If you carry this variant, your retina is fighting a constant low-level immune battle. Your eye pressure may be higher because inflammation increases fluid production and decreases fluid drainage in the anterior chamber. You might notice floaters, blurred vision, or sensitivity to bright light more readily than others. Over time, this creates a hostile environment for your optic nerve.

VEGF is the master signal for building and maintaining blood vessels in your retina. It tells your endothelial cells to grow new capillaries, maintains the blood-retinal barrier, and keeps retinal blood vessels stable. Without adequate VEGF signaling, retinal blood vessels become fragile and inefficient. With too much VEGF, vessels overgrow and become abnormally permeable, leaking fluid into the retina and anterior chamber.

The VEGF -634G>C variant affects how much VEGF your eye produces in response to hypoxia and metabolic stress. Roughly 35% of people carry variants that shift retinal neovascularization patterns and increase intraocular pressure risk through abnormal vessel permeability. Your eye’s vascular system is exquisitely sensitive to VEGF dosing; too little causes ischemia, too much causes edema and pressure elevation.

If you have this variant, your retinal vasculature may be overreacting to stress signals, producing excess fluid in the anterior chamber and increasing drainage resistance. You might notice floaters that seem to appear after stress or high blood pressure spikes. Your intraocular pressure may fluctuate more than typical because your vessels are hypersensitive to inflammatory triggers.

APOE is your body’s primary cholesterol and lipid carrier in the blood and cerebrospinal fluid, including the eye. It regulates how lipids are transported to your retina and how efficiently your retinal cells clear lipid debris. APOE also modulates neuroinflammation and mitochondrial function in retinal cells. Variants in APOE shift how efficiently your body handles lipids and how prone your retinal vessels are to atherosclerosis.

The APOE4 allele, carried by roughly 25-40% of people depending on ancestry, increases lipid accumulation in retinal vessel walls and accelerates atherosclerosis of the ophthalmic artery, the main blood supply to your eye. This creates vascular stiffness and impairs the delicate autoregulation of intraocular pressure. When blood vessel walls are lipid-laden and inflexible, they cannot adapt to pressure changes, and your eye’s drainage system becomes less efficient.

If you carry APOE4, your retinal blood vessels may be accumulating lipids even if your serum cholesterol is normal. You might have slightly blurred vision in low light, early presbyopia, or difficulty with contrast sensitivity. Your intraocular pressure may be more resistant to standard drugs because the underlying problem is vascular stiffness, not just fluid overproduction.

VDR is the receptor that transduces vitamin D signals into your retinal immune cells and vascular endothelium. Vitamin D is not just about bone health; it’s a potent immune modulator that prevents excessive inflammation and supports healthy vessel function. VDR variants change how efficiently your retinal cells respond to vitamin D, affecting immune tolerance, vascular stability, and intraocular pressure homeostasis.

Common VDR variants (FokI, BsmI, ApaI, TaqI) affect vitamin D responsiveness, and roughly 30-50% of people carry variants that reduce retinal immune tolerance to vitamin D and increase susceptibility to ocular inflammation. Your eye’s immune system is exquisitely calibrated; when VDR signaling is weak, your retina overreacts to minor stressors, producing excess inflammatory cytokines and increasing fluid accumulation in the anterior chamber.

If you have VDR variants associated with reduced responsiveness, you may notice that your intraocular pressure rises during winter months or times of low sun exposure. Your eyes might feel more inflamed or irritated during high pollen seasons. Standard vitamin D supplementation may not move the needle on your pressure because your retinal cells simply aren’t responding efficiently to the signal.

MTHFR is the enzyme that converts folate into the active methylated form needed for DNA synthesis, methylation reactions, and critically, for producing tetrahydrofolate (BH4), a cofactor required for nitric oxide synthase. Nitric oxide is your eye’s master molecule for vascular relaxation, blood flow regulation, and intraocular pressure homeostasis. Without adequate BH4, your retinal vessels cannot produce enough nitric oxide, and they become vasoconstricted and stiff.

The MTHFR C677T variant, carried by roughly 40% of people of European ancestry, reduces enzyme efficiency by 40-70%, impairing BH4 production and nitric oxide synthesis in your retinal vessels. This means your eyes are chronically vasoconstricted, blood flow to your optic nerve head is compromised, and intraocular pressure regulation becomes dysregulated. Elevated homocysteine, a side effect of impaired MTHFR function, further damages retinal endothelium.

If you have MTHFR C677T, your eye pressure may be stubbornly high despite drops because your vessels simply cannot relax enough to improve drainage. You might have cold hands and feet (a sign of vascular dysfunction), sensitivity to light, or floaters that worsen with stress. Your optic nerve head perfusion is likely marginal, even if your pressure reading seems only mildly elevated.

SOD2 is the primary antioxidant enzyme protecting your mitochondria from oxidative damage. Your photoreceptors and retinal pigment epithelium are among the most metabolically active cells in your body, consuming enormous amounts of ATP and generating free radicals in the process. SOD2 neutralizes the superoxide radicals produced by mitochondrial respiration, protecting your retina from oxidative aging and photoreceptor death. When SOD2 is inefficient, oxidative stress accumulates in your retinal cells, triggering inflammation and vascular dysfunction.

The SOD2 Val16Ala variant is common; roughly 40% of people are homozygous for the Ala16 allele, which reduces mitochondrial antioxidant capacity and accelerates oxidative stress accumulation in photoreceptors and retinal pigment epithelium. This doesn’t just cause vision loss; it triggers chronic low-level inflammation in the retina that drives intraocular pressure elevation through immune activation and vascular dysfunction.

If you carry SOD2 Val16Ala, your retina is aging faster than average at the cellular level. You might notice presbyopia earlier than expected, difficulty adapting to darkness, or dry eye that’s hard to treat. Your intraocular pressure may be elevated partly because your retinal immune system is overreacting to oxidative damage, producing excess inflammatory mediators that increase aqueous humor production.